CHEK2 Gene Mutation: Clinical Trials

2 trials for CHEK2 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow CHEK2 Gene Mutation: new trials by email Literature Review of CHEK2 Gene Mutation trials Research Report on CHEK2 Gene Mutation

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
Tamoxifen 10 mg Tablet, Intermittent caloric restriction, Step counter Device - BRCA Mutation, PALB2 Gene Mutation
Phase 2CompletedEuropean Institute of Oncology1102024-06-212026-09-11
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Laboratory Biomarker Analysis, Pharmacological Study, Talazoparib - ATM Gene Mutation, ATR Gene Mutation
Phase 2CompletedSWOG Cancer Research Network512017-03-032021-06-23

Narrower conditions

Breast Carcinoma In Situ (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)

Broader conditions

Adenocarcinoma (1)  ·  Breast Diseases (1)  ·  Breast Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma in Situ (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Ductal, Lobular, and Medullary (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Tablets (1)  ·  Tamoxifen (1)  ·  talazoparib (1)

Sponsors

European Institute of Oncology (1)  ·  SWOG Cancer Research Network (1)

Countries

Canada (1)  ·  Italy (1)  ·  United States (1)

Top investigators

Bernardo Bonanni, MD (1)  ·  Vassiliki Papadimitrakopoulou (1)

Results publications

PMID 39226292

NIH funding

2023 (1), U10CA180888 (1)